Current epidemiology and trends in invasive haemophilus influenzae disease-United States, 1989-2008

Clinical Infectious Diseases

Volumn 53, Issue 12, 2011, Pages 1230-1236

  MacNeil, Jessica R ^a   Cohn, Amanda C ^a   Farley, Monica ^b   Mair, Raydel ^a   Baumbach, Joan ^c   Bennett, Nancy ^d   Gershman, Ken ^e   Harrison, Lee H ^f   Lynfield, Ruth ^g   Petit, Susan ^h   Reingold, Arthur ⁱ   Schaffner, William ^j   Thomas, Ann ^k   Coronado, Fatima ^a   Zell, Elizabeth R ^a   Mayer, Leonard W ^a   Clark, Thomas A ^a   Messonnier, Nancy E ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW MEXICO DEPARTMENT OF HEALTH   (United States)

^d NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^e Colorado Department of Public Health and Environment ^*  (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g MINNESOTA DEPARTMENT OF HEALTH   (United States)

^h CDC   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k OREGON DEPARTMENT OF HUMAN SERVICES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AMERICAN INDIAN; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; GROUPS BY AGE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HUMAN; INCIDENCE; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROTYPE; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; SEROTYPING; UNITED STATES; YOUNG ADULT;

EID: 81855192056     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir735     Document Type: Article

References (28)

1. Farley MM, Stephens DS, Brachman PS Jr, Harvey RC, Smith JD, Wenger JD. Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC Meningitis Surveillance Group. Ann Intern Med 1992; 116:806-12. (Pubitemid 23034757)
2. Takala AK, Eskola J, Van Alphen L. Spectrum of invasive Haemophilus influenzae type b disease in adults. Arch Intern Med 1990; 150:2573-6.
3. Steinhart R, Reingold AL, Taylor F, Anderson G, Wenger JD. Invasive Haemophilus influenzae infections in men with HIV infection. JAMA 1992; 268:3350-2.
4. Kostman JR, Sherry BL, Fligner CL, et al. Invasive Haemophilus influenzae infections in older children and adults in Seattle. Clin Infect Dis 1993; 17:389-96. (Pubitemid 23261452)
5. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993; 269:221-6.
6. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis 1990; 162:1316-23.
7. Bisgard KM, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis 1998; 4:229-37. (Pubitemid 28311209)
8. CDC. Progress toward elimination of Haemophilus influenzae type b disease among infants and children-United States, 1987-1995. MMWR Morb Mortal Wkly Rep 1996; 45:901-6.
9. CDC. Progress toward eliminating Haemophilus influenzae type b disease among infants and children-United States, 1987-1997. MMWR Morb Mortal Wkly Rep 1998; 47:993-8.
10. Singleton R, Hammitt L, Hennessy T, et al. The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease. Pediatrics 2006; 118:e421-9. (Pubitemid 46085381)
11. Singleton R, Holve S, Groom A, et al. Impact of immunizations on the disease burden of American Indian and Alaska native children. Arch Pediatr Adolesc Med 2009; 163:446-53.
12. Dworkin MS, Park L, Borchardt SM. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons . or 5 65 years old. Clin Infect Dis 2007; 44:810-6. (Pubitemid 46365305)
13. Ribeiro GS, Reis JN, Cordeiro SM, et al. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. J Infect Dis 2003; 187:109-16. (Pubitemid 36034478)
14. Adderson EE, Byington CL, Spencer L, et al. Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era? Pediatrics 2001; 108:E18.
15. Bender JM, Cox CM, Mottice S, et al. Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine. Clin Infect Dis 2010; 50:e41-6.
16. Schuchat A, Hilger T, Zell E, et al. Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis 2001; 7:92-9. (Pubitemid 32173338)
17. Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. StatMed 1997; 16:791-801. (Pubitemid 27165684)
18. CDC. Available at: http://www.cdc.gov/nchs/data/nnhsd/Estimates/nnhs/ Estimates-PaymentSource-Tables.pdf. Accessed 24 May 2011.
19. Ladhani S, Slack MP, Heath PT, Von Gottberg A, Chandra M, Ramsay ME. Invasive Haemophilus influenzae disease, Europe, 1996-2006. Emerg Infect Dis 2010; 16:455-63.
20. Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, Fisman DN. Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine 2010; 28:4073-8.
21. Erwin AL, Nelson KL, Mhlanga-Mutangadura T, et al. Characterization of genetic and phenotypic diversity of invasive nontypeable Haemophilus influenzae. Infect Immun 2005; 73:5853-63. (Pubitemid 41193022)
22. Lacross NC, Marrs CF, Patel M, Sandstedt SA, Gilsdorf JR. High genetic diversity of nontypeable Haemophilus influenzae isolates from two children attending a day care center. J Clin Microbiol 2008; 46:3817-21.
23. Prymula R, Schuerman L. 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix. Expert Rev Vaccines 2009; 8:1479-500.
24. Murphy TF. Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges. Expert Rev Vaccines 2005; 4:843-53. (Pubitemid 43040905)
25. Watt JP, Wolfson LJ, O'Brien KL, et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 2009; 374:903-11.
26. Progress introducing Haemophilus influenzae type b vaccine in lowincome countries, 2004-2008. Wkly Epidemiol Rec 2008; 83:61-7.
27. Ladhani S, Slack MP, Heys M, White J, Ramsay ME. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign. Arch Dis Child 2008; 93:665-9.
28. Trotter CL, Ramsay ME, Slack MP. Rising incidence of Haemophilus influenzae type b disease in England andWales indicates a need for a second catch-up vaccination campaign. Commun Dis Public Health 2003; 6:55-8.